Matches in Wikidata for { <http://www.wikidata.org/entity/Q98621621> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q98621621 description "2020ജൂലൈ 16 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q98621621 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q98621621 description "scientific article published on 16 July 2020" @default.
- Q98621621 description "wetenschappelijk artikel" @default.
- Q98621621 description "наукова стаття, опублікована 16 липня 2020" @default.
- Q98621621 name "Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States" @default.
- Q98621621 name "Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States" @default.
- Q98621621 type Item @default.
- Q98621621 label "Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States" @default.
- Q98621621 label "Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States" @default.
- Q98621621 prefLabel "Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States" @default.
- Q98621621 prefLabel "Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States" @default.
- Q98621621 P1433 Q98621621-D1DDF42C-FD83-4C48-ABFA-C0E3A09F1516 @default.
- Q98621621 P1476 Q98621621-6479EE25-DBDC-4B5C-8DCA-EFB45FB2AF0A @default.
- Q98621621 P2093 Q98621621-057678DF-36D9-4A1A-86F8-380F748C4BF0 @default.
- Q98621621 P2093 Q98621621-2461D695-11F2-40DB-BFEC-025152590BC8 @default.
- Q98621621 P2093 Q98621621-3B6ADF4A-2629-424C-8E57-F33DB318CBE3 @default.
- Q98621621 P2093 Q98621621-61403F05-D0BA-42D9-A657-A31555087901 @default.
- Q98621621 P2093 Q98621621-7233D68F-BBBA-498D-9036-B0775D478A8D @default.
- Q98621621 P2093 Q98621621-9A26145D-F72B-4904-BF9B-8D4C1A1A19F5 @default.
- Q98621621 P2093 Q98621621-BE56CA97-EEF7-42A1-A5FC-CFBD36002791 @default.
- Q98621621 P2093 Q98621621-FECCBC72-5399-4938-9BDB-CB92F81DE58E @default.
- Q98621621 P31 Q98621621-724C90CD-3E6A-452E-8FEF-A9CD56C9FE7C @default.
- Q98621621 P356 Q98621621-2BFE79F0-71FF-41F9-B84C-DEB802EAE36A @default.
- Q98621621 P577 Q98621621-09582814-C0D6-4953-9D22-F668D4D89A0E @default.
- Q98621621 P698 Q98621621-190BB043-75B9-4ACF-84B1-F6CF97083950 @default.
- Q98621621 P921 Q98621621-17BD6217-1069-4077-A5D9-57D81BFE55B3 @default.
- Q98621621 P356 J.CLGC.2020.07.006 @default.
- Q98621621 P698 32826180 @default.
- Q98621621 P1433 Q332266 @default.
- Q98621621 P1476 "Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States" @default.
- Q98621621 P2093 "Blanca Homet Moreno" @default.
- Q98621621 P2093 "Haojie Li" @default.
- Q98621621 P2093 "James Luke Godwin" @default.
- Q98621621 P2093 "Karl Patterson" @default.
- Q98621621 P2093 "Oliver Hale" @default.
- Q98621621 P2093 "Ronac Mamtani" @default.
- Q98621621 P2093 "Yang Meng" @default.
- Q98621621 P2093 "Yizhen Lai" @default.
- Q98621621 P31 Q13442814 @default.
- Q98621621 P356 "10.1016/J.CLGC.2020.07.006" @default.
- Q98621621 P577 "2020-07-16T00:00:00Z" @default.
- Q98621621 P698 "32826180" @default.
- Q98621621 P921 Q13896859 @default.